Dosage and cost: Sildenafil is available through Hims by prescription in 25-, 50-, or 100-milligram (mg) pills, starting at $4 per dose. Brand-name Viagra is also available through Hims in 25-, 50 ...

and the only cost attributed is the cost for the specific medication prescribed or supplements chosen,” according to a Hims customer service representative. The process for obtaining a ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission or other tangible benefit. Optum Store, Optum Perks, and Healthline ...

Price – The cost per dose of Hims Hard ... the active ingredient in Viagra, unfortunately Hims hard mints no longer contain ...

But Hims & Hers Health Inc. — the online telehealth platform best known for selling hair-loss treatments, Viagra and Cialis ... platform at an affordable price continues to resonate with ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Hims is also a telehealth company that offers ... much more affordable than branded options. For instance, Viagra can cost around $90 per pill, whereas its generic, sildenafil, can cost around ...

The ad is for Hims, a men's health startup know for selling generic Viagra and hair-loss medications. It's an approach that's getting a lot of attention as investors are wagering that consumers ...

SG Americas Securities LLC trimmed its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 34.1% in the ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...

Telehealth company Hims & Hers Health (HIMS 3.09%) has been great for investors this year by almost any standard; share prices have nearly doubled from a year ago. Yet shareholders aren't feeling ...